CEO Blog: comment on clinical data released at ESMO 2017 Congress

September 21st, 2017 by Blog Author

A short note on the clinical data we presented at ESMO. This is early data from our first-in-human clinical study, so it is important to keep that perspective. Over the course of the next 6 months we plan on reporting on this and other clinical studies at various international and local oncology conferences. Progressively, the […]

Read More

CEO Blog explains Noxopharm Brain Cancer Announcement 29 August 2017

September 3rd, 2017 by Blog Author

Is it possible that Noxopharm can do something meaningful for patients with brain cancer, where so many others have failed? We believe so, with our recent announcement going some way to justifying that belief. Yes, what we have just announced is laboratory data. And, yes, we have a long way to go before we can […]

Read More